(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

EZ CAP

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

EZ CAP

ST13

US500000079367529

Class

1, 5

Filing

79367529

Registration

7330334

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

31

Latest update

11/09/2024

Classification

Registered

Trademark type

Word

Nice classes

1, 5

Filing date

12/26/2022

Registration date

03/19/2024

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/19/2024

Last transaction

03/19/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

CN

Examiner

STINSON,JENNIFER ELLE

Law office

O20

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

SHANGHAI WEIHUAN BIOTECH. CO., LTD.

Representatives

Charles Ho Barron & Young PLLC

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Enzymes for industrial purposes; industrial chemicals; chemical reagentsother than for medical or veterinary purposes; nucleic acid sequences and chemical reagents for other than medical and veterinary purposes; nucleic acid for laboratory use; nucleic acid for laboratory useDNARNA and/or mRNA oligonucleotidesmodified nucleosides and reagents for use in genetic research for nucleic acid synthesischemical reagents for medical research use; chemical substances for analyses in laboratoriesother than for medical or veterinary purposes; diagnostic preparationsother than for medical or veterinary purposes; reagent paperother than for medical or veterinary purposes; chemical preparations for scientific purposesother than for medical or veterinary use; biochemical catalysts; cryogenic preparations in solidliquid or gas state for use in chilling and freezing

Class 5

Pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations acting on the central nervous system; nucleic acid sequences and chemical reagentsmRNA and mRNA capping reagents for pharmaceutical purposes and medical purposes; nucleic acid sequences and chemical reagents for medical and veterinary purposes; reagents and media for medical and veterinary diagnostic purposes; immunostimulants; antiseptics; antivirals; cellular function activating agents for medical purposes; vaccine preparations; depuratives for the body; biocides; biological preparations for the treatment of cancer

Publications

History of USPTO decisions and trademark events.

31 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

11/09/2024

FICS

FINAL DISPOSITION NOTICE SENT TO IB

10/20/2024

FIMP

FINAL DISPOSITION PROCESSED

10/19/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

06/20/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

03/19/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

03/19/2024

GPNX

NOTIFICATION PROCESSED BY IB

01/02/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/02/2024

PUBO

PUBLISHED FOR OPPOSITION

01/02/2024

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

12/13/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

12/13/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/13/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/28/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/21/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/21/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/21/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/17/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/17/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/17/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

11/17/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

11/17/2023

RFNT

REFUSAL PROCESSED BY IB

11/07/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

10/19/2023

RFRR

REFUSAL PROCESSED BY MPU

10/19/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

10/04/2023

CNRT

NON-FINAL ACTION WRITTEN

10/03/2023

DOCK

ASSIGNED TO EXAMINER

09/25/2023

MAFR

APPLICATION FILING RECEIPT MAILED

04/25/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/20/2023

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

04/19/2023

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

04/13/2023

Continuous trademark protection

Get notified about every new filing that threatens EZ CAP or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.